Literature DB >> 6310562

Isolation of opiate binding components by affinity chromatography and reconstitution of binding activities.

T M Cho, B L Ge, C Yamato, A P Smith, H H Loh.   

Abstract

Rat brain membranes exhibiting stereospecific opiate binding activity were solubilized by sonication and detergent treatment. The active material could be bound to an affinity column containing 6-succinylmorphine but could not be eluted with free agonist. Although two protein peaks could be eluted with NaCl, neither possessed binding activity; however, one of the peaks (A), in combination with an acidic lipid fraction, eluted subsequently from the column, showed stereospecific binding. Opiate ligands of the mu type bound to this protein/lipid mixture with an order of affinities closely correlating with those of the original membrane but one to two orders of magnitude lower; binding of delta, kappa, and sigma prototype opioids was considerably less. The protein/lipid mixture also competed with the membranes for mu ligands. These results suggest that the isolated protein-lipid complex may be a component of the opiate receptor and, specifically, the mu receptor or binding site. However, because of the lower affinities of mu opiates for this complex, it is conceivable that some essential membrane component is still missing. Preliminary analysis of peak A indicates that it contains a broad spectrum of protein bands, but it remains to be seen which of these are essential for activity.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6310562      PMCID: PMC384214          DOI: 10.1073/pnas.80.17.5176

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

1.  Measurement of protein-binding phenomena by gel filtration.

Authors:  J P HUMMEL; W J DREYER
Journal:  Biochim Biophys Acta       Date:  1962-10-08

2.  Binding of narcotics and narcotic antagonists to triphosphoinositide.

Authors:  Y C Wu; T M Cho; H H Loh; E L Way
Journal:  Biochem Pharmacol       Date:  1976-07-01       Impact factor: 5.858

3.  A simple direct assay for cyclic AMP in plasma and other biological samples using an improved competitive protein binding technique.

Authors:  K C Tovey; K G Oldham; J A Whelan
Journal:  Clin Chim Acta       Date:  1974-11-08       Impact factor: 3.786

4.  Interaction of Vibrio cholerae enterotoxin with cell membranes.

Authors:  P Cuatrecasas
Journal:  Biochemistry       Date:  1973-08-28       Impact factor: 3.162

5.  Stereospecific binding of narcotics to brain cerebrosides.

Authors:  H H Loh; T M Cho; Y C Wu; E L Way
Journal:  Life Sci       Date:  1974-06-01       Impact factor: 5.037

6.  Opiate receptor binding: effects of enzymatic treatments.

Authors:  G W Pasternak; S H Snyder
Journal:  Mol Pharmacol       Date:  1974-03       Impact factor: 4.436

7.  Stereospecific morphine adsorption to phosphatidyl serine and other membranous components of brain.

Authors:  L G Abood; W Hoss
Journal:  Eur J Pharmacol       Date:  1975-05       Impact factor: 4.432

8.  Coupling of a new, active morphine derivative to sepharose for affinity chromatography.

Authors:  E J Simon; W P Dole; J M Hiller
Journal:  Proc Natl Acad Sci U S A       Date:  1972-07       Impact factor: 11.205

9.  Stereospecific binding of the potent narcotic analgesic (3H) Etorphine to rat-brain homogenate.

Authors:  E J Simon; J M Hiller; I Edelman
Journal:  Proc Natl Acad Sci U S A       Date:  1973-07       Impact factor: 11.205

10.  Rapid, sensitive spectrophotometric method for quantitative determination of sulfatides.

Authors:  E L Kean
Journal:  J Lipid Res       Date:  1968-05       Impact factor: 5.922

View more
  6 in total

1.  Solubilization and characterization of mu, delta, and kappa opioid binding sites from guinea pig brain: physical separation of kappa receptors.

Authors:  Y Itzhak; J M Hiller; E J Simon
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

2.  Inhibition of dopamine-sensitive adenylate cyclase by opioids: possible involvement of physically associated mu- and delta-opioid receptors.

Authors:  A N Schoffelmeer; F Hogenboom; A H Mulder
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-03       Impact factor: 3.000

3.  Purification to apparent homogeneity of a mu-type opioid receptor from rat brain.

Authors:  T M Cho; J Hasegawa; B L Ge; H H Loh
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

4.  Highly selective photoaffinity labeling of mu and delta opioid receptors.

Authors:  C Garbay-Jaureguiberry; A Robichon; V Daugé; P Rossignol; B P Roques
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

5.  Purification of the opiate receptor of NG108-15 neuroblastoma-glioma hybrid cells.

Authors:  W F Simonds; T R Burke; K C Rice; A E Jacobson; W A Klee
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

6.  Molecular characterization of a new immunoglobulin superfamily protein with potential roles in opioid binding and cell contact.

Authors:  P R Schofield; K C McFarland; J S Hayflick; J N Wilcox; T M Cho; S Roy; N M Lee; H H Loh; P H Seeburg
Journal:  EMBO J       Date:  1989-02       Impact factor: 11.598

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.